12/31/2015 | CV | Market Commentary: Outlook 2016: Convertibles primary market seen in line to higher after disappointing 2015
|
5/28/2015 | SP | Deutsche Bank plans quarterly review notes linked to Actavis
|
5/12/2015 | BKCVIG | S&P lowers Allergan
|
5/11/2015 | PP | Market Commentary: Convertibles flat; Actavis, Anthem mandatories edge up; SunEdison plans $750 million deal
|
5/11/2015 | CV | Market Commentary: Convertibles flat; Actavis, Anthem mandatories edge up; SunEdison plans $750 million deal
|
5/11/2015 | CV | Market Commentary: Morning Commentary: Actavis preferreds pare early gain after strong earnings; FXCM quiet
|
4/15/2015 | SP | New Issue: Deutsche Bank prices $1.26 million trigger phoenix autocallables on Actavis
|
4/8/2015 | SP | Deutsche Bank plans trigger phoenix autocallables linked to Actavis
|
4/6/2015 | PF | S&P adds seven issues to S&P U.S. Preferred Stock index, removes five
|
3/17/2015 | BKCVIG | Fitch cuts Allergan, affirms Actavis
|
3/16/2015 | PP | Market Commentary: Salix convertibles add on sweetened Valeant deal; Amarin extends gains; Actavis in action
|
3/16/2015 | CV | Market Commentary: Salix convertibles add on sweetened Valeant deal; Amarin extends gains; Actavis in action
|
3/13/2015 | BK | Actavis enters into up to $4.7 billion cash bridge credit agreement
|
3/10/2015 | PP | Market Commentary: Convertibles weaker as stocks sell off; BPZ Resources files bankruptcy; Akorn tumbles
|
3/10/2015 | CV | Market Commentary: Convertibles weaker as stocks sell off; BPZ Resources files bankruptcy; Akorn tumbles
|
3/9/2015 | PP | Market Commentary: RTI issues expand on swap on Alcoa takeout; Starwood trades better; Actavis at 101.5-102
|
3/9/2015 | CV | Market Commentary: RTI issues expand on swap on Alcoa takeout; Starwood trades better; Actavis at 101.5-102
|
3/5/2015 | EMHYMUPFPV | Market Commentary: Energy Transfer, Abbott, John Deere price; supply tops $60 billion; Coach, Microsoft firm
|
3/5/2015 | IG | Market Commentary: Energy Transfer, Abbott, John Deere price; supply tops $60 billion; Coach, Microsoft firm
|
3/3/2015 | IG | Market Commentary: Actavis megadeal prices; Exxon upsizes; Exxon trades; AT&T firms; Verizon mixed
|
3/3/2015 | PP | Market Commentary: Planned Gogo convertible looks cheap but lacks stock borrow; Goodrich remains strong
|
3/3/2015 | CV | Market Commentary: Planned Gogo convertible looks cheap but lacks stock borrow; Goodrich remains strong
|
3/3/2015 | EMHYMUPFPV | Market Commentary: Actavis megadeal prices; Exxon upsizes; Exxon trades; AT&T firms; Verizon mixed
|
3/3/2015 | IG | Market Commentary: Morning Commentary: High-grade bonds stable; MetLife, Microsoft mostly flat in early trade
|
3/2/2015 | CV | Actavis greenshoe exercise increases convertibles to $5.06 billion
|
3/2/2015 | EMHYMUPFPV | Market Commentary: MetLife, Discover, American Airlines price; Actavis megadeal on deck; Discover, MetLife firm
|
3/2/2015 | IG | Market Commentary: MetLife, Discover, American Airlines price; Actavis jumbo bond on deck; Discover, MetLife firm
|
2/26/2015 | CV | Market Commentary: American Tower mandatory adds on debut; Prologis expands on hedge; salesforce contracts
|
2/25/2015 | PP | Market Commentary: New Actavis adds on debut; American Tower adds in the gray; Huron, Chesapeake improve
|
2/25/2015 | CV | Market Commentary: New Actavis adds on debut; American Tower adds in the gray; Huron, Chesapeake improve
|
2/25/2015 | CV | Market Commentary: Morning Commentary: Upsized Actavis adds, in line; Tesla Motors’ 1.25% convertibles in mid 80s
|
2/25/2015 | CV | New Issue: Actavis sells upsized $4.6 billion mandatory convertible preferreds at 5.5%, up 22.5%
|
2/24/2015 | PP | Market Commentary: American Tower on tap with $1.25 billion mandatory; planned Actavis mandatory upsized
|
2/24/2015 | CV | Market Commentary: American Tower on tap with $1.25 billion mandatory; planned Actavis mandatory upsized
|
2/24/2015 | CV | Planned Actavis mandatory convertible issue upsized to $4.6 billion
|
2/24/2015 | CV | Market Commentary: Morning Commentary: American Tower on tap with $1.25 billion mandatory; secondary softens
|
2/23/2015 | PP | Market Commentary: Salix flat to lower in active trade after merger news; Spectrum sinks on patent ruling
|
2/23/2015 | CV | Market Commentary: Salix flat to lower in active trade after merger news; Spectrum sinks on patent ruling
|
2/23/2015 | CV | Actavis revises talk on $4.2 billion mandatory convertibles to 5.5%-5.75%, up 20%-22.5%
|
2/20/2015 | CV | Market Commentary: Convertibles mostly softer; Brocade down with lower shares after earnings; Yandex higher
|
2/19/2015 | PP | Market Commentary: Health care names weaker after Actavis launches large mandatory; Priceline slightly better
|
2/19/2015 | CV | Market Commentary: Health care names weaker after Actavis launches large mandatory; Priceline slightly better
|
2/19/2015 | CV | Market Commentary: Morning Commentary: Priceline jumps; SolarCity drops outright; Actavis offers mandatory
|
2/19/2015 | CV | Actavis to sell $4.2 billion mandatory convertible preferreds at 5.75%-6.25%, up 17.5%-22.5%
|
1/8/2015 | BKBWCAHYLMLW | Valeant cuts leverage to 3.5x, holds out prospect of more debt paydowns
|
12/22/2014 | BK | Actavis gets $30.9 billion bridge loan, $5 billion term loan for buyout
|
11/18/2014 | BK | Actavis gives more details on new debt for Allergan acquisition
|
11/17/2014 | IG | S&P affirms Actavis
|
11/17/2014 | BKBWIG | Actavis plans to issue $27.5 billion of new debt at an average of 4.25% to fund Allergan merger
|
11/17/2014 | IG | Moody’s affirms Actavis
|
10/15/2014 | SP | New Issue: Barclays sells $1.78 million contingent income autocallables on Actavis
|
10/6/2014 | SP | Barclays plans contingent income autocallable notes linked to Actavis
|
8/19/2014 | SP | RBC plans to price phoenix autocallable notes linked to Actavis
|
7/3/2014 | BK | Actavis restates $750 million revolver on acquiring Forest Labs
|
7/1/2014 | BKHYIG | Moody's lifts Forest Labs from junk
|
7/1/2014 | BKHYIG | Fitch rates Forest Labs BBB-; affirms Actavis
|
6/12/2014 | HYLM | Actavis gets needed consents to guarantee Forest Laboratories notes
|
6/10/2014 | EMHYMUPFPV | Market Commentary: Actavis, Johnson, RBC price, primary spree continues; new issues mixed in aftermarket
|
6/10/2014 | IG | Market Commentary: Actavis, Johnson, RBC price, primary spree continues; new issues mixed in aftermarket trading
|
6/10/2014 | IG | New Issue: Actavis prices $3.7 billion of senior notes in four tranches
|
6/10/2014 | BKIG | Moody's rates Actavis notes Baa3
|
6/10/2014 | BKIG | S&P gives Actavis debt BBB-
|
6/10/2014 | BKIG | Fitch assigns Actavis bonds BBB-
|
6/10/2014 | IG | Actavis prepares to sell four-part offering of senior notes
|
6/9/2014 | HYLM | Actavis extends offers to guarantee Forest Lab notes for acquisition
|
5/22/2014 | HYLM | Actavis offers to guarantee Forest Laboratories' notes for acquisition
|
4/3/2014 | BK | Actavis gets commitments for $2 billion tranche A-2 term loans
|
3/5/2014 | BKIG | S&P rates Actavis loan BBB-
|
2/19/2014 | IG | S&P downgrades Actavis
|
2/19/2014 | BK | Actavis gets commitment for bridge, term loans to fund Forest merger
|
2/19/2014 | BKIG | Actavis gets commitment for bridge, term loans, notes to acquire Forest
|
2/18/2014 | BKIG | Actavis secures bridge loan for $25 billion acquisition of Forest Labs
|
2/18/2014 | BKHYIG | Moody's might upgrade Forest Labs
|
2/12/2014 | SP | UBS plans phoenix autocallable notes due 2015 linked to Actavis
|
2/5/2014 | SP | New Issue: HSBC prices $3.81 million return enhanced notes linked to four stocks
|
1/29/2014 | SP | HSBC plans one-year return enhanced notes linked to four stocks
|